Literature DB >> 18234365

Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study.

Espen Haugen1, Yutaka Furukawa, Azra Isic, Michael Fu.   

Abstract

BACKGROUND: Adiponectin, which is a collagen-like plasma protein produced by adipose tissue, has in general anti-atherogenic and anti-inflammatory effects. Recently it was shown to be elevated in chronic heart failure patients. However whether this holds true in the elderly heart failure patients who are often associated with malnutrition remains unknown.
MATERIALS AND METHODS: Patients with severe heart failure (n=92, average age >70 years, NYHA III-IV) and age-matched healthy volunteers (n=70) as control were enrolled in the present study. Serum levels of adiponectin and NT-pro BNP were measured.
RESULTS: Adiponectin levels were significantly increased in heart failure patients for those >70 years old as compared with control group. There were higher adiponectin levels in non-ischemic heart failure as compared with those with ischemic cause. Serum adiponectin levels were positively associated with serum NT-pro BNP levels. There was a strong trend of higher adiponectin levels in those who died as compared with those who survived.
CONCLUSION: Serum adiponectin levels were increased in the very elderly heart failure patients, and particularly in those with underlying non-ischemic origin. Adiponectin levels appear to be associated with increased mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234365     DOI: 10.1016/j.ijcard.2007.12.002

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  17 in total

1.  Determinants of adiponectin levels in patients with chronic systolic heart failure.

Authors:  Andreia Biolo; Rei Shibata; Noriyuki Ouchi; Shinji Kihara; Mina Sonoda; Kenneth Walsh; Flora Sam
Journal:  Am J Cardiol       Date:  2010-02-20       Impact factor: 2.778

Review 2.  The evolving role of adiponectin as an additive biomarker in HFrEF.

Authors:  Tahnee Sente; Andreas Gevaert; An Van Berendoncks; Christiaan J Vrints; Vicky Y Hoymans
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

3.  Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease.

Authors:  Ken Shinmura
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 4.  Direct effects of adipokines on the heart: focus on adiponectin.

Authors:  Min Park; Gary Sweeney
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

5.  Association of adiponectin with left ventricular mass in blacks: the Jackson Heart Study.

Authors:  Aurelian Bidulescu; Jiankang Liu; Solomon K Musani; Ervin R Fox; Tandaw E Samdarshi; Daniel F Sarpong; Viola Vaccarino; Peter W Wilson; Donna K Arnett; Rebecca Din-Dzietham; Herman A Taylor; Gary H Gibbons
Journal:  Circ Heart Fail       Date:  2011-08-12       Impact factor: 8.790

6.  Impact of obesity on plasma B-type natriuretic peptide levels in Japanese community-based subjects.

Authors:  Megumi Koizumi; Hiroyuki Watanabe; Yoshihiro Kaneko; Kenji Iino; Masaru Ishida; Toshimitsu Kosaka; Yutaka Motohashi; Hiroshi Ito
Journal:  Heart Vessels       Date:  2011-04-28       Impact factor: 2.037

7.  What can adiponectin say about left ventricular function?

Authors:  Flora Sam; Kenneth Walsh
Journal:  Heart       Date:  2009-11-23       Impact factor: 5.994

Review 8.  New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.

Authors:  Deepa M Gopal; Flora Sam
Journal:  J Cardiovasc Transl Res       Date:  2013-04-23       Impact factor: 4.132

9.  Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).

Authors:  Stephan von Haehling; Mitja Lainscak; Wolfram Doehner; Piotr Ponikowski; Giuseppe Rosano; Jens Jordan; Piotr Rozentryt; Mathias Rauchhaus; Rostislav Karpov; Vsevolod Tkachuk; Yelena Parfyonova; Andrey Y Zaritskey; Eugeniy V Shlyakhto; John G Cleland; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

10.  Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure.

Authors:  Hoyoun Won; Seok-Min Kang; Min-Jeong Shin; Jaewon Oh; Namki Hong; Sungha Park; Sang-Hak Lee; Yangsoo Jang; Namsik Chung
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.